VAERS reports by lot

Janssen (J&J) COVID-19 lot 1816027: VAERS reports

68 VAERS reports list lot 1816027 as a Janssen (J&J) COVID-19 vaccine, received between 2021-05-19 and 2022-11-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
68
Reports
18%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5322%
Neurological4519%
Cardiac / Cardiovascular3916%
Gastrointestinal2912%
Musculoskeletal2912%
Respiratory94%
Dermatological (non-injection-site)94%
Thrombotic / Hematological83%
Injection-site / Local reaction83%
Allergic / Anaphylactic62%
Psychiatric / Neuropsychiatric52%
Reproductive / Menstrual21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Wisconsin20
Indiana10
Washington9
Illinois6
New Mexico5
California4
Michigan4
Arizona3
Ohio3
Alabama1
Florida1
Minnesota1

Reports by month received

2021-055
2021-0611
2021-077
2021-081
2021-0922
2021-1010
2021-113
2021-123
2022-013
2022-031
2022-081
2022-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.